In this note, while we briefly touch upon Pfizer’s performance in 2024, we focus on the impact on PFE stock and how 2025 ...
Pfizer Inc. (NYSE:PFE – Get Free Report) saw unusually large options trading activity on Thursday. Traders acquired 251,131 ...
With a market cap of $144.8 billion, New York ... Pfizer raised its full-year revenue guidance to $61 billion - $64 billion and adjusted EPS guidance to $2.75 - $2.95. However, the stock fell ...
Citi analyst Geoff Meacham maintained a Hold rating on Pfizer (PFE – Research Report) today. The company’s shares closed yesterday at ...
Pfizer's stock experienced a notable decline on Friday at the New York Stock Exchange, falling 1.6% to $26.03 per share following news of a $59.7 million settlement payment. The settlement stems from ...
It doesn't matter your age or experience: taking full advantage of the stock market and investing ... attractive and discounted stocks. New York-based Pfizer markets a wide range of drugs and ...
Bernstein analyst Courtney Breen maintained a Hold rating on Pfizer (PFE – Research Report) today and set a price target of $32.00. The ...
Pfizer on Tuesday appealed a federal judge's refusal to award the drugmaker $75.2 million from a more than decade-old insider ...
Taking full advantage of the stock market and investing with confidence ... favorable times to buy high-momentum stocks. New York-based Pfizer markets a wide range of drugs and vaccines.